Method for producing large lots of final sterile Poly-ICLC suitable for clinical use with reduced toxicity at effective dose levels, and method for using Poly-ICLC to regulate genes, and method for using Poly-ICLC to treat certain human and veterinary infectious, neoplastic and autoimmune disorders.

 
Web www.patentalert.com

< Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products

> Peptides and compositions which modulate apoptosis
~ 00469